Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-05-26 4:51 pm Sale | 13G | VECTIVBIO HLDG AG VECT | Novo Holdings A/S | 0 0% | -3,339,484 (Position Closed) | View |
| 2023-05-15 5:16 pm Unchanged | 13D | RENEO PHARMACEUTICALS INC RPHM | Novo Holdings A/S | 3,430,377 10.2% | 0 (Unchanged) | View |
| 2023-02-24 4:38 pm Sale | 13D | LAVA THERAPEUTICS N V SHS LVTX | Novo Holdings A/S | 3,070,558 11.7% | -256,754 (-7.72%) | View |
| 2023-02-21 4:28 pm Purchase | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 8,378,336 19.9% | 3,864,000 (+85.59%) | View |
| 2023-02-17 4:32 pm Purchase | 13G | LANZATECH GLOBAL INC LNZA | Novo Holdings A/S | 15,814,845 8.1% | 15,814,845 (New Position) | View |
| 2023-02-02 1:24 pm Sale | 13G | VECTIVBIO HLDG AG VECT | Novo Holdings A/S | 3,339,484 5.3% | -182,535 (-5.18%) | View |
| 2023-02-02 1:24 pm Sale | 13G | EVOTEC SE AMERICAN DEPOSITARY EVO | Novo Holdings A/S | 17,444,807 9.8% | -450,000 (-2.51%) | View |
| 2023-01-04 4:20 pm Sale | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Novo Holdings A/S | 0 0% | -2,534,465 (Position Closed) | View |
| 2023-01-03 4:30 pm Purchase | 13G | DISC MEDICINE INC IRON | Novo Holdings A/S | 2,340,772 13.8% | 2,340,772 (New Position) | View |
| 2022-12-28 2:51 pm Sale | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Novo Holdings A/S | 2,534,465 6.7% | -1,169,526 (-31.57%) | View |
| 2022-12-12 4:26 pm Sale | 13G | ARCELLX INC ACLX | Novo Holdings A/S | 1,750,000 4% | -757,076 (-30.20%) | View |
| 2022-11-28 1:57 pm Sale | 13G | ARCELLX INC ACLX | Novo Holdings A/S | 2,507,076 5.7% | -1,509,802 (-37.59%) | View |
| 2022-11-17 1:30 pm Purchase | 13G | RALLYBIO CORP COM RLYB | Novo Holdings A/S | 2,296,007 6.2% | 2,296,007 (New Position) | View |
| 2022-11-03 4:07 pm Sale | 13G | MINERVA SURGICAL INC UTRS | Novo Holdings A/S | 1,322,473 4.5% | -734,659 (-35.71%) | View |
| 2022-10-24 12:46 pm Sale | 13D | MILESTONE PHARMACEUTICALS INC MIST | Novo Holdings A/S | 1,378,538 4.6% | -719,175 (-34.28%) | View |
| 2022-10-03 4:15 pm Unchanged | 13D | LAVA THERAPEUTICS N V SHS LVTX | Novo Holdings A/S | 3,327,312 12.9% | 0 (Unchanged) | View |
| 2022-09-30 4:54 pm Unchanged | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 4,514,336 19.2% | 0 (Unchanged) | View |
| 2022-09-30 4:52 pm Unchanged | 13D | GALECTO INC GLTO | Novo Holdings A/S | 2,497,791 9.8% | 0 (Unchanged) | View |
| 2022-09-30 4:51 pm Unchanged | 13D | IO BIOTECH INC IOBT | Novo Holdings A/S | 3,277,932 11.4% | 0 (Unchanged) | View |
| 2022-09-30 4:48 pm Unchanged | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Novo Holdings A/S | 3,703,991 9.8% | 0 (Unchanged) | View |